Researchers from the Harvard Medical School have developed an AI that has the ability to anticipate whether a tuberculosis (TB) strain will have a resistance to 10 first- and second-line treatments. Fortunately, researchers at Harvard Medical School The researchers used machine learning algorithms to predict which TB strains would be resistant to all first-line treatments in order of their prevalence. Current figures suggest that one-tenth of new TB cases are resistant to multiple medications.
Researchers from the Harvard Medical School have developed an AI that has the ability to anticipate whether a tuberculosis (TB) strain will have a resistance to 10 first- and second-line treatments. The researchers used machine learning algorithms to predict which TB strains would be resistant to all first-line treatments in order of their prevalence. Current figures suggest that one-tenth of new TB cases are resistant to multiple medications.